14
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Expression of the c-myc Oncogene under Control of an Immunoglobulin Enhancer in Eµ-myc Transgenic Mice

, &
Pages 1436-1444 | Received 14 Oct 1986, Accepted 22 Dec 1986, Published online: 31 Mar 2023

LITERATURE CITED

  • Adams, J. M., S. Gerondakis, E. Webb, L. M. Corcoran, and S. Cory. 1983. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc. Natl. Acad. Sci. USA 80:1982–1986.
  • Adams, J. M., S. Gerondakis, E. Webb, J. Mitchell, O. Bernard, and S. Cory. 1982. Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proc. Natl. Acad. Sci. USA 79:6966–6970.
  • Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (London) 318:533–538.
  • Alt, F. W., N. Rosenberg, V. Enea, E. Siden, and D. Baltimore. 1982. Multiple immunoglobulin heavy-chain gene transcripts in Abelson murine leukemia virus-transformed lymphoid cell lines. Mol. Cell. Biol. 2:386–400.
  • Atchison, M. L., and R. P. Perry. 1986. Tandem kappa immunoglobulin promoters are equally active in the presence of the kappa enhancer: implications for models of enhancer function. Cell 46:253–262.
  • Banerji, J., L. Olson, and W. Schaffner. 1983. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33:729–740.
  • Bernard, O., S. Cory, S. Gerondakis, E. Webb, and J. M. Adams. 1983. Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J. 2:2375–2383.
  • Brinster, R. L., H. Y. Chen, M. E. Trumbauer, M. K. Yagle, and R. D. Palmiter. 1985. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc. Natl. Acad. Sci. USA 82:4438–4442.
  • Calabi, F., and M. S. Neuberger. 1985. Chromosome translocation activates heterogeneously initiated, bipolar transcription of a mouse c-myc gene. EMBO J. 4:667–674.
  • Calame, K. 1985. Mechanisms that regulate immunoglobulin gene expression. Annu. Rev. Immunol. 3:159–195.
  • Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299.
  • Coppola, J. A., and M. D. Cole. 1986. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature (London) 320:760–763.
  • Corcoran, L. M., S. Cory, and J. M. Adams. 1985. Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma. Cell 40:71–79.
  • Cory, S. 1986. Activation of cellular oncogenes in haemopoietic cells by chromosome translocations. Adv. Cancer Res. 47:189–234.
  • Cory, S., S. Gerondakis, and J. M. Adams. 1983. Interchromosomal recombination of the cellular oncogene c-myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange. EMBO J. 2:697–703.
  • Cory, S., M. Graham, E. Webb, L. Corcoran, and J. M. Adams. 1985. Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J. 4:675–681.
  • de Villiers, J., L. Olson, J. Banerji, and W. Schaffner. 1982. Analysis of the transcriptional enhancer effect. Cold Spring Harbor Symp. Quant. Biol. 47:911–919.
  • Ephrussi, A., G. M. Church, S. Tonegawa, and W. Gilbert. 1985. B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134–140.
  • Gerondakis, S., S. Cory, and J. M. Adams. 1984. Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell 36:973–982.
  • Gerster, T., D. Picard, and W. Schaffner. 1986. During B-cell differentiation enhancer activity and transcription rate of immunoglobulin heavy chain genes are high before mRNA accumulation. Cell 45:45–52.
  • Gillies, S. D., S. L. Morrison, V. T. Oi, and S. Tonegawa. 1983. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33:717–728.
  • Gonda, T., D. Sheiness, and J. M. Bishop. 1982. Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues. Mol. Cell. Biol. 2:617–624.
  • Grosschedl, R., and D. Baltimore. 1985. Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 41:885–897.
  • Grosschedl, R., D. Weaver, D. Baltimore, and F. Constantini. 1984. Introduction of a μ immunoglobulin gene into the mouse germline: specific expression in lymphoid cells and synthesis of functional antibody. Cell 38:647–658.
  • Hamlyn, P., and T. H. Rabbitts. 1983. Translocation joins c-myc and immunoglobulin γ1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene. Nature (London) 304:135–139.
  • Keath, E. J., A. Kelekar, and M. D. Cole. 1984. Transcriptional activation of the translocated c-myc oncogene in mouse plasmacytomas: similar RNA levels in tumour and proliferating normal cells. Cell 37:521–528.
  • Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
  • Kemp, D., A. W. Harris, and J. M. Adams. 1980. Transcripts of the immunoglobulin Cµ gene vary in structure and splicing during lymphoid development. Proc. Natl. Acad. Sci. USA 77:7400–7404.
  • Klein, G., and E. Klein. 1985. myc/Ig juxtaposition by chromosomal translocations: some new insights, puzzles and paradoxes. Immunol. Today 6:208–215.
  • Langdon, W. Y., A. W. Harris, S. Cory, and J. M. Adams. 1986. The c-myc oncogene perturbs B lymphocyte development in Eµ-myc transgenic mice. Cell 47:11–18.
  • Leder, A., P. K. Pattengale, A. Kuo, T. A. Stewart, and P. Leder. 1986. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45:485–495.
  • Leder, P., J. Battey, G. Lenoir, C. Moulding, W. Murphy, H. Potter, T. Stewart, and R. Taub. 1983. Translocations among antibody genes in human cancer. Science 222:765–771.
  • Lennon, G. G., and R. P. Perry. 1985. Cµ-containing transcripts initiate heterogeneously within the IgH enhancer region and contain a novel 5′-nontranslatable exon. Nature (London) 318:475–478.
  • Maeda, H., D. Kitamura, A. Kudo, K. Araki, and T. Watanabe. 1986. Trans-acting nuclear protein responsible for induction of rearranged human immunoglobulin heavy chain gene. Cell 45:25–33.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning, a laboratory manual, p. 122–127. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Mercola, M., X. Wang, J. Olsen, and K. Calame. 1983. Transcriptional enhancer elements in the mouse immunoglobulin heavy chain locus. Science 221:663–665.
  • Mosthaf, L., M. Pawlita, and P. Gruss. 1985. A viral enhancer element specifically active in human haemopoietic cells. Nature (London) 315:597–600.
  • Neuberger, M. S. 1983. Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. EMBO J. 2:1373–1378.
  • Nishikura, K., A. Ar-Rushidi, J. Erikson, R. Watt, G. Rovera, and C. M. Croce. 1983. Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. Proc. Natl. Acad. Sci. USA 80:4822–4826.
  • Nishikura, K., J. Erikson, A. Ar-Rushidi, K. Heubner, and C. M. Croce. 1985. The translocated c-myc oncogene of Raji Burkitt lymphoma cells is not expressed in human lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 82:2900–2904.
  • Palacios, R., G. Henson, M. Steinmetz, and J. P. McKearn. 1984. Interleukin-3 supports growth of mouse pre-B-cell clones in vitro. Nature (London) 309:126–131.
  • Parnes, J. M., and J. G. Seidman. 1982. Structure of wild-type and mutant mouse ß2-microglobulin genes. Cell 29:661–669.
  • Prehn, J., M. Mercola, and K. Calame. 1984. Translocation affects normal c-myc promoter usage and activates fifteen cryptic c-myc transcription starts in plasmacytoma M603. Nucleic Acids Res. 12:8987–9007.
  • Rabbitts, T. H., A. Forster, P. Hamlyn, and R. Baer. 1984. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature (London) 309:592–597.
  • Schöler, H. R., and P. Gruss. 1985. Cell type-specific transcriptional enhancement in vitro requires the presence of trans-acting factors. EMBO J. 4:3005–3013.
  • Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705–716.
  • Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (London) 319:154–158.
  • Stanton, L. W., R. Watt, and K. B. Marcu. 1983. Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature (London) 303:401–406.
  • Stanton, L. W., J. Yang, L. A. Eckhardt, L. J. Harris, B. K. Birshtein, and K. B. Marcu. 1984. Products of a reciprocal chromosome translocation involving the c-myc gene in a murine plasmacytoma. Proc. Natl. Acad. Sci. USA 81:829–833.
  • Stewart, T. A., A. R. Bellvé, and P. Leder. 1984. Transcription and promoter usage of the myc gene in normal somatic and spermatogenic cells. Science 226:707–710.
  • Stewart, T. A., P. K. Pattengale, and P. Leder. 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38:627–637.
  • Taub, R., C. Moulding, J. Battey, W. Murphy, T. Vasicek, G. M. Lenoir, and P. Leder. 1984. Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells. Cell 36:339–348.
  • Thomas, P. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77:5201–5205.
  • Voss, S. D., U. Schlokat, and P. Gruss. 1986. The role of enhancers in the regulation of cell type-specific transcriptional control. Trends Biochem. Sci. 11:287–289.
  • Wang, X., and K. Calame. 1985. The endogenous immunoglobulin heavy chain enhancer can activate tandem VH promoters separated by a large distance. Cell 43:659–665.
  • Wasylyk, B., C. Wasylyk, P. Augereau, and P. Chambon. 1983. The SV40 72 bp repeat preferentially potentiates transcription starting from proximal natural or substitute promoter elements. Cell 32:503–514.
  • Wasylyk, C., and B. Wasylyk. 1986. The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cells. EMBO J. 5:553–560.
  • Yang, J., S. R. Bauer, J. F. Mushinski, and K. B. Marcu. 1985. Chromosome translocations clustered 5′ of the murine c-myc gene qualitatively effect promoter usage: implications for the site of normal myc regulation. EMBO J. 4:1441–1447.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.